For all its “made in India” pitch, Covaxin is the most expensive Covid-19 vaccine in India

A new change in regulation has resurfaced old wounds about vaccine prices in India.

At Rs1,200 ($16.42) a dose, Bharat Biotech’s Covaxin, a Covid-19 vaccine fully developed and manufactured in India, is the most pricey option available at private hospitals in India. The vaccine is not only more expensive than the other locally manufactured option, Covishield, but costs more than even the imported Sputnik V.

Covaxin’s pricing is “nothing but governmental sanction for Bharat Biotech to make super profits,” says Malini Aisola, co-convener of the All India Drug Action Network (AIDAN), an independent collective of healthcare professionals and nonprofits. “These unethically inflated prices have no correlation to its cost of production,” she says.

Read the rest of this story on Become a member to get unlimited access to Quartz’s journalism.


For Android Mobile users Ilwareed Online has an App available on Google Play Store, with this App you can get the latest News and Political Analysis every minute.
Download Ilwareed Now.

Follow us on Twitter #ilwareed and Facebook #ilwareedonline